American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. [electronic resource]
Producer: 20000113Description: 1939-55 p. digitalISSN:- 0732-183X
- Anticarcinogenic Agents -- adverse effects
- Bone Density -- drug effects
- Breast Neoplasms -- epidemiology
- Cardiovascular Diseases -- epidemiology
- Cataract -- epidemiology
- Endometrial Neoplasms -- chemically induced
- Estrogen Antagonists -- adverse effects
- Expert Testimony
- Female
- Humans
- Incidence
- Menopause -- drug effects
- Raloxifene Hydrochloride -- adverse effects
- Randomized Controlled Trials as Topic
- Risk Assessment
- Tamoxifen -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.